Lung Cancer | Specialty

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Targeted Therapy Research Booms in Biomarker-Positive NSCLC

October 28th 2020

Shirish M. Gadgeel, MD, MBBS, highlights some of the recent targeted therapy advances in NSCLC and how ongoing research is taking the paradigm to the next level.

Identifying, Treating Resistance to TKIs Are Next Step in EGFR+ NSCLC

October 28th 2020

Christina Baik, MD, MPH, highlights the evolving role of EGFR inhibition in the NSCLC space.

Pralsetinib and Selpercatinib Expand the RET+ NSCLC Paradigm

October 27th 2020

Justin F. Gainor, MD, discusses the recent FDA approvals of pralsetinib and selpercatinib, which led to expanded treatment options for patients with non–small cell lung cancer who harbor RET rearrangements.

Adagrasib Shows Early Activity in KRAS G12C+ NSCLC, CRC, and Other Solid Tumors

October 26th 2020

Adagrasib, a potent and selective inhibitor of KRAS G12C, showcased encouraging clinical activity with an acceptable safety profile in patients with KRAS G12C–positive non–small cell lung cancer, colorectal cancer, and other solid tumors.

Takeaways on Treatment of Early-Stage NSCLC

October 26th 2020

The Future of Lung Cancer Treatment

October 26th 2020

Mesothelioma: A Look at DREAM3R and PrECOG Trial

October 26th 2020

Risk of Pneumonitis Post-Chemoradiation in Stage 3 NSCLC

October 26th 2020

Fundamentals of Mesothelioma

October 26th 2020

Considering PD-L1 and EGFR Status With I/O in Stage 3 NSCLC

October 26th 2020

Trials in Limited-Stage Small-Cell Lung Cancer

October 26th 2020

PACIFIC Trial in Stage 3 NSCLC

October 26th 2020

Future of Neoadjuvant I/O in ES NSCLC

October 26th 2020

Treatment for Progressive Small-Cell Lung Cancer

October 26th 2020

Neoadjuvant I/O for ES NSCLC: Key Trials from ESMO 2020

October 26th 2020

Treatment Options in Small–Cell Lung Cancer

October 26th 2020

Recent Advances in Small-Cell Lung Cancer

October 26th 2020

Key Trials in Neoadjuvant I/O for ES NSCLC

October 26th 2020

Treatment for PD-L1 High/Low/Negative Non–Small Cell Lung Cancer

October 26th 2020

Role of Neoadjuvant I/O in ES NSCLC

October 26th 2020